Direct-to-Consumer Advertising of Prescription Drugs: The Evidence Says No
- 1 September 2002
- journal article
- Published by SAGE Publications in Journal of Marketing & Public Policy
- Vol. 21 (2) , 194-201
- https://doi.org/10.1509/jppm.21.2.194.17595
Abstract
There is little rationale for direct-to-consumer advertising of prescription drugs. Most new drugs offer little if any therapeutic advantage over existing products. Direct-to-consumer advertisements frequently downplay safety information. Physicians are highly ambivalent about prescribing advertised drugs requested by patients. There is no evidence that direct-to-consumer advertising results in any improvement in health outcomes.Keywords
This publication has 23 references indexed in Scilit:
- Public Policy Issues in Direct-to-Consumer Advertising of Prescription DrugsJournal of Marketing & Public Policy, 2002
- Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?BMJ, 2002
- Direct-to-consumer prescription drug advertising and the publicJournal of General Internal Medicine, 1999
- Physicians, pharmaceutical sales representatives, and the cost of prescribingArchives of Family Medicine, 1996
- The effect of industry-independent drug information on the prescribing of benzodiazepines in general practiceEuropean Journal of Clinical Pharmacology, 1994
- Factors Linked to the Prescribing of Benzodiazepines by General Practice Principals and TraineesFamily Practice, 1992
- Therapeutic Ratings and End‐of‐Phase II Conferences: Initiatives to Accelerate the Availability of Important New Drugs Kenneth I. Kaitin, PhDThe Journal of Clinical Pharmacology, 1991
- Physicians' Knowledge of Prescribing for the ElderlyJournal of the American Geriatrics Society, 1985
- Scientific versus commercial sources of influence on the prescribing behavior of physiciansThe American Journal of Medicine, 1982
- Rational prescribing and sources of informationSocial Science & Medicine, 1982